Search results
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing...
Nature· 7 days agoCancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical ...
Scientists create tailored drug for aggressive breast cancer
Medical Xpress· 6 days agoScientists have used breast cancer cells' weakness against themselves by linking a tumor-selective...
Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual...
Nature· 15 hours agoThe findings demonstrated the efficacy of using ƒ-MWCNT-CUR-BSA-MTX as a vehicle for efficient co-delivery of CUR and MTX in cancer treatment. The MTT colorimetric method ...
New customised drug developed to fight aggressive breast cancer
Investing.com· 6 days agoNew customised drug developed to fight aggressive breast cancer
PKMYT1, a potential 'Achilles heel' of treatment resistant ER+ breast cancers with the poorest...
Medical Xpress· 3 days agoLooking to identify new vulnerabilities in this type of cancer that could lead to improved...
FDA approves first DLL3 × CD3 bispecific T-cell engager for lung cancer
Nature· 4 days agoDiscover the world’s best science and medicine | Nature.com
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 4 days agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this ...
Get Ready for ASCO 2024 Annual Meeting | Newswise
Newswise· 6 days agoASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings a
Epithalon Peptide and Skin Cells - LA Weekly
LA Weekly· 5 days agoImage credit: Pixabay
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 7 days agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...